Injection anxiety can be a reason dental patients cancel or delay appointments, and the moment right before a needle touches the mucosa is usually where that anxiety peaks. DentalJect is built around that exact moment. It’s a pre-injection topical anesthetic device made by VCS Medical in Boca Raton, Florida, and it targets the seconds before an injection rather than the injection itself.
The device was developed by Dr. Jacob Liebovici, a practicing dentist, which matters in a category where a lot of operatory products are designed by people who’ve never held a handpiece. DentalJect received FDA 510(k) clearance in June 2025, putting it in a small group of newer chairside devices that have gone through that clearance process recently. The FDA’s 510(k) database provides additional information on the device’s clearance.
What is DentalJect?
DentalJect is a drug-free, cryo-anesthesia device. Instead of a gel or liquid anesthetic, it uses a cool gas delivered through a targeted nozzle to numb the oral mucosa before an injection. The company’s own description frames it as a way to block local pain receptors at the surface so the injection that follows is less uncomfortable, but it’s worth being precise about what that means clinically.
This is a topical, pre-injection step. It does not replace a local anesthetic, and it isn’t a sedation device. The clinician still administers the nerve block or infiltration afterward. DentalJect’s job is limited to the surface tissue, and understanding that boundary is the difference between reading it accurately and overselling what it does.
How DentalJect actually works in the chair
The mechanics are straightforward enough to walk through step by step:
1. The clinician attaches a reusable, autoclavable applicator to the coolant canister with a twist-and-lock connection.
2. The rotatable shielded guide is positioned against or near the target site, whether that’s buccal tissue, the palate, or a posterior mandibular area.
3. A burst of cool gas hits the mucosa and numbs it in about 2 seconds.
4. The clinician injects immediately. There’s no waiting period for the anesthetic to absorb, because nothing needs to absorb.
That last point is the operational difference from most topical anesthetics on the market. Benzocaine 20% gel, the standard sitting in most operatories today, typically needs a minute or two to take effect before an injection can follow, and it can spread past the area it was applied to. DentalJect’s gas stays where the nozzle points it, and because it works by cooling rather than by drug absorption, the clinician doesn’t have to build in a waiting window.
The applicators are reusable and autoclavable, which fits a normal sterilization workflow rather than requiring disposable single-use tips. Each canister is rated for up to 40 applications, so a single canister covers a meaningful stretch of a typical day’s schedule before it needs replacing.
The differentiator: no absorption wait
Most of what separates dental topicals from each other comes down to onset time and where the product stays once applied. The same focus on efficiency has shaped other technologies used in dentistry, including laser technology, which has been applied across a range of dental procedures. Because DentalJect works by cooling the tissue rather than delivering a drug that needs to diffuse into it, there’s no absorption lag between application and injection, which is the main practical difference between it and gel-based topicals.
For a hygienist or dentist running a full schedule, a minute or two saved per injection isn’t dramatic on its own. Multiplied across a day of restorative work, extractions, and periodontal procedures, it adds up to real chair time. That’s the kind of efficiency case that matters more to a practice owner reading a spec sheet than to a single patient in the chair, and it’s the strongest practical argument for stocking it.
Where it fits against other topicals
Dental practices already have options: benzocaine 20% gel, topical lidocaine, Oraqix (a lidocaine/prilocaine periodontal gel) and refrigerant sprays like Gebauer’s. Each of those works differently. Benzocaine and lidocaine gels are drug-based and need contact time to take effect. Oraqix is applied subgingivally and is positioned mainly for periodontal procedures rather than general injection sites. Refrigerant sprays cool tissue in a way that’s conceptually closer to DentalJect, though DentalJect’s shielded guide is built specifically to direct the gas at a controlled target rather than a broader spray pattern.
DentalJect is also positioned for sites that are harder to anesthetize topically, including the palate and posterior mandibular block areas, where gels can be difficult to keep in place long enough to work. That’s a meaningful distinction for clinicians who’ve dealt with a benzocaine application sliding off a moving palatal surface before it’s had time to numb anything.
Who this is actually built for
DentalJect is a prescription device sold to dental professionals, not a consumer product, and it’s marketed through the manufacturer and dental distributors rather than direct to patients. The intended users are dentists, hygienists and practice owners making purchasing decisions for an operatory, not individual patients researching their own care.
Within that audience, a few use cases stand out based on where a fast, no-wait topical actually changes the patient experience:
Pediatric patients. Kids have short patience for anything that takes a minute or two to kick in, and a 2-second application is easier to manage chairside than asking a child to sit still while a gel works.
Needle-phobic adults. Anxiety tends to build during any delay between numbing and injection. Cutting that delay to zero removes one more thing for an anxious patient to sit through.
Palatal injections. These are notoriously hard to numb topically with a gel that won’t stay put, which is where a directed gas application has a clear practical edge.
Practices managing cancellations tied to injection anxiety. If a practice tracks no-shows or last-minute cancellations back to fear of needles, a faster, more controlled pre-injection step is a reasonable lever to pull.
Strengths and trade-offs
Fast, predictable onset. Numbing the mucosa in about 2 seconds with no absorption wait is the headline mechanical advantage, and it’s the reason the rest of the product exists.
Targeted delivery. The rotatable shielded guide gives clinicians more control over exactly where the cold gas lands, which matters on small or awkward sites like the palate.
Reusable hardware. Autoclavable applicators mean the ongoing consumable is just the coolant canister, not a disposable tip for every patient.
Every device has trade-offs, and DentalJect is no exception. It’s a device that adds a step and a piece of equipment to the operatory workflow, which means staff need to learn the twist-and-lock attachment and shielded guide positioning before it becomes routine. It’s also strictly a topical, pre-injection product, so practices still need their existing local anesthetic protocol for the injection itself. And because it’s a prescription device sold through the manufacturer and distributors rather than over the counter, adopting it means going through a professional purchasing channel rather than a simple retail order.
None of these are dealbreakers for a practice weighing whether to add it, but they’re worth knowing before ordering a canister for every chair. Practices evaluating new chairside devices may also be interested in how 3D technology is changing dental equipment design, from digital scanning and modeling to newer approaches to dental equipment.
Is It Worth It?
DentalJect solves a narrow, specific problem: the gap between applying a topical anesthetic and being able to inject. If that gap is costing a practice chair time or contributing to canceled appointments from anxious patients, the case for stocking it is straightforward. It’s not a replacement for local anesthetic, and it’s not a sedation option, so it needs to be evaluated for exactly what it is rather than what a general “pain-free dentistry” pitch might imply.
For practices treating a lot of pediatric patients, needle-phobic adults, or difficult palatal sites, it’s a reasonable addition to the operatory toolkit. For a practice happy with its current benzocaine or lidocaine workflow and not looking to change routine, it’s a smaller priority. Either way, it’s the kind of device worth evaluating on its own mechanics rather than on marketing language, and the FDA’s device clearance letters are a fair place to start for anyone who wants to see the clearance details firsthand.
